Skip to content

Effectiveness of Expiratory Muscle Strength Training for Improving Communication in ALS

Effectiveness of Expiratory Muscle Strength Training for Improving Communication in ALS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05003167
Enrollment
13
Registered
2021-08-12
Start date
2021-01-01
Completion date
2022-06-01
Last updated
2023-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Brief summary

A tele-health treatment study for individuals with early stage ALS with the aim to improve communication, cough response, and respiratory strength. All participants complete a respiratory strength training program using an Expiratory Muscle Strength Training (EMST 150) device from the comfort of their homes for 6 weeks.

Detailed description

The investigators are looking for people with early stage ALS to participate in a completely tele-health (no in-person visits required) treatment study examining the effects of an Expiratory Muscle Strength Training device (EMST-150) on communication, cough, and respiratory strength. Participants will be required to attend 2 virtual baseline assessment sessions followed by 12 additional virtual training sessions (2 per week for 6 weeks). Participants should plan to be actively enrolled in the study for \ 10 weeks (3 weeks of baseline monitoring followed by 6 weeks of training). Participants will also be required to fill out a series of questionnaires assessing the EMST's effectiveness via tele-health.

Interventions

All participants will forcefully breathe out into an Expiratory Muscle Strength Training device (EMST-150) 25 times per day for 6 weeks. The EMST device will be set at a moderate intensity level (50% of each participant's maximum expiratory pressure).

Sponsors

National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH
Purdue University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

All participants enrolled will receive the intervention.

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of ALS * Within the early stages of disease progression (i.e., able to talk, breathe, and eat independently) * Speaker of English * Have a family member/caregiver willing to assist as needed * Have access to an electronic device and internet for tele-health

Exclusion criteria

* A history of neurological disease (besides ALS) * A history of asthma or respiratory problems (e.g., COPD, emphysema) * A history of head, neck, or chest surgery (except mastectomy) * A history of smoking within the last 5 years * Reliance on mechanical ventilation (including CPAP)

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline to Post-treatment for Maximum Expiratory PressureBaseline 2 (week 2), Pre-Training (week 3), and Post-Training (week 10)Change in expiratory muscle strength throughout the study duration measured by the participant blowing into a pressure meter

Secondary

MeasureTime frameDescription
Change From Baseline to Post-Treatment in Utterance LengthBaseline 1 (week 1) and Post-Training (week 10)Change in utterance length (# of syllables produced on one breath) throughout the study duration. Participant read the Rainbow Passage and data were collected from this task.
Change From Baseline to Post-Treatment in Number of PausesBaseline 1 (week 1) and Post-Training (week 10)Change in the total number of pauses that included breathing (breath pauses). Participant read the Rainbow Passage and data were collected from this task.
Change From Baseline to Post-Treatment in Syntactic Location of PausesBaseline 1 (week 1) and Post-Training (week 10)Change in the location of pauses while breathing produced while reading. We determined where participants took breaths while reading the Rainbow Passage and categorized them according to syntax. Categories included at a major boundary (at the end of an independent clause marked by a period) and at a boundary that is not related to syntax (not a major or minor syntactical location). The number of pauses at each category of boundaries were converted to a percent of the total breaths taken while reading the passage.
Telehealth SatisfactionPost-Training (week 10)Participants rated 15 statements with a 5-point Likert scale ranging from strongly disagree (1) to strongly agree (5). Example statements include: I can easily talk to my health-care provider, I can hear my health-care provider clearly, I can see my health-care provider as if we met in person, I think the care provided via telemedicine is consistent, and I receive adequate attention, telemedicine provides for my health care need, and overall, I am satisfied with the quality of service being provided via telemedicine. Total scores range from 0-75 and individual statement scores ranged from 1-5, with higher scores indicating higher satisfaction with the telepractice modality.
Change From Pre-Training to Post-Training in Communication Participation Item BankPre-Training (week 3) and Post-Training (week 10)Participants were instructed to use a 4-point Likert scale (3: not at all; 2: a little; 1: quite a bit; 0: very much) to rate if/how their ALS impacts ten hypothetical communicative situations. Participants total scores were then added together, ranging from 0-30, and converted to a T-score ranging from 24.2-71.0. High scores are more favorable, indicating that the participant feels that ALS impacts their communicative participation less than those with lower scores.
Peak Expiratory Flow RateBaseline 2 (week 2), Pre-training (week 3), Post-Training (week 10)Change in cough strength (as measured by peak expiratory flow rate) throughout the study duration, measured using a flow meter that the participant coughs into - single coughs. Data from baseline 2 and pre-training were averaged for the pre--training value.
ALS Function Rating Scale RevisedBaseline 1 (week 1) and Post-Training (week 10)A survey that quantifies change in disease progression throughout the study duration. Participants rate how 12 physical functions are impacted by their ALS. For each function, participants are provided with a 4-point Likert scale to rate whether they still have complete control of that function (4) or no ability to perform that function (0). Total scores range from 0 to 48, with lower scores indicating more severe symptoms and higher scores and less severe symptoms.
Psychosocial Impact of Assistive Devices ScalePost-treatment (week 10)A survey assessing how the training device/modality impacts patient's psychosocial functions. The PIADS includes 12 items for competence, 6 for adaptability, and 8 for self-esteem. Participants use a 7-point Likert scale to rate the impact of a device on each item: a maximum negative impact (-3), somewhat negative impact (-2 or -1), zero impact (0), somewhat positive impact (1 or 2), maximum positive impact (3). Total scores range from -78 (maximum negative impact) to 78 (maximum positive impact).
Tele-health Session AttendanceMeasured at the end of training across the entire training period% of training sessions scheduled and attended by participants throughout the study duration
Adherence to Training ProtocolMeasured each week of training across the entire training durationNumber of of training exhalations completed (25 exhalations into the device, 5 days per week) by participants throughout the study duration
Change From Baseline to Post-Treatment in ALS Quality of Life ScaleBaseline 1 (week 1) and Post-Training (week 10)The ALS Quality of Life Scale-Revised (ALSQOL-R) (Simmons, 2015) was used to measure how ALS impacts their quality of life in six domains: negative emotion, interaction with people and the environment, intimacy, religiosity, physical symptoms, and bulbar function. Participants rate whether they strongly disagree (0) or strongly agree (10) with 46 statements. Each domain score is given an average value between 0 (worse) and 10 (best). Total scores on the ALSQOL-R range from 0-460, but an average score ranging from 0-10 is computed by dividing the total score by the total number of items completed by the participant (usually 46). Higher scores reflect a higher quality of life. A survey assessing how each participant feels ALS impacts quality of life, and how that changes throughout the study duration. Total scores range from 0-460, with higher scores indicating greater contributions of ALS to quality of life.

Countries

United States

Participant flow

Participants by arm

ArmCount
Expiratory Muscle Strength Training
All participants will forcefully breathe out into an Expiratory Muscle Strength Training device (EMST-150) 25 times per day for 6 weeks. The EMST device will be set at a moderate intensity level (50% of each participant's maximum expiratory pressure). Expiratory Muscle Strength Training (EMST-150): All participants will forcefully breathe out into an Expiratory Muscle Strength Training device (EMST-150) 25 times per day for 6 weeks. The EMST device will be set at a moderate intensity level (50% of each participant's maximum expiratory pressure).
13
Total13

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicExpiratory Muscle Strength Training
Age, Continuous59.46 years
STANDARD_DEVIATION 8.63
ALSFRS-R baseline38.8 units on a scale
STANDARD_DEVIATION 3.75
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
11 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Montreal Cognitive Assessment baseline28.23 units on a scale
STANDARD_DEVIATION 1.42
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
13 Participants
Region of Enrollment
United States
13 participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 13
other
Total, other adverse events
0 / 13
serious
Total, serious adverse events
0 / 13

Outcome results

Primary

Change From Baseline to Post-treatment for Maximum Expiratory Pressure

Change in expiratory muscle strength throughout the study duration measured by the participant blowing into a pressure meter

Time frame: Baseline 2 (week 2), Pre-Training (week 3), and Post-Training (week 10)

Population: All participants with baseline, pre-training, and post-treatment maximum expiratory pressure values were included. The second baseline and pre-training values were averaged to obtain the pre-training value which was used along with the week 10 value (post-treatment).

ArmMeasureGroupValue (MEAN)Dispersion
Expiratory Muscle Strength TrainingChange From Baseline to Post-treatment for Maximum Expiratory PressurePre-training average66.10 cmH2OStandard Deviation 41.77
Expiratory Muscle Strength TrainingChange From Baseline to Post-treatment for Maximum Expiratory PressurePost-training (week 10)83.75 cmH2OStandard Deviation 45.99
Comparison: A mixed model ANOVA with session (pre-post-training) as a main effect and participant as a random factor was run via SAS 9.4. Alpha was set at .05.p-value: 0.001ANOVA
Secondary

Adherence to Training Protocol

Number of of training exhalations completed (25 exhalations into the device, 5 days per week) by participants throughout the study duration

Time frame: Measured each week of training across the entire training duration

ArmMeasureValue (MEAN)Dispersion
Expiratory Muscle Strength TrainingAdherence to Training Protocol90.65 percent of at-home training completedStandard Deviation 16.94
Secondary

ALS Function Rating Scale Revised

A survey that quantifies change in disease progression throughout the study duration. Participants rate how 12 physical functions are impacted by their ALS. For each function, participants are provided with a 4-point Likert scale to rate whether they still have complete control of that function (4) or no ability to perform that function (0). Total scores range from 0 to 48, with lower scores indicating more severe symptoms and higher scores and less severe symptoms.

Time frame: Baseline 1 (week 1) and Post-Training (week 10)

Population: All participants with baseline (week 1) and post-training (week 10) scores were included.

ArmMeasureGroupValue (MEAN)
Expiratory Muscle Strength TrainingALS Function Rating Scale RevisedBaseline (week 1)39 score on a scale
Expiratory Muscle Strength TrainingALS Function Rating Scale RevisedPost-training (week 10)37 score on a scale
Secondary

Change From Baseline to Post-Treatment in ALS Quality of Life Scale

The ALS Quality of Life Scale-Revised (ALSQOL-R) (Simmons, 2015) was used to measure how ALS impacts their quality of life in six domains: negative emotion, interaction with people and the environment, intimacy, religiosity, physical symptoms, and bulbar function. Participants rate whether they strongly disagree (0) or strongly agree (10) with 46 statements. Each domain score is given an average value between 0 (worse) and 10 (best). Total scores on the ALSQOL-R range from 0-460, but an average score ranging from 0-10 is computed by dividing the total score by the total number of items completed by the participant (usually 46). Higher scores reflect a higher quality of life. A survey assessing how each participant feels ALS impacts quality of life, and how that changes throughout the study duration. Total scores range from 0-460, with higher scores indicating greater contributions of ALS to quality of life.

Time frame: Baseline 1 (week 1) and Post-Training (week 10)

Population: All participants with pre- and post-training scores on the scale. Lower scores reflect less effect of ALS on quality of life.

ArmMeasureGroupValue (MEAN)Dispersion
Expiratory Muscle Strength TrainingChange From Baseline to Post-Treatment in ALS Quality of Life Scalepre-training5.97 units on a scaleStandard Deviation 0.99
Expiratory Muscle Strength TrainingChange From Baseline to Post-Treatment in ALS Quality of Life Scalepost-training5.94 units on a scaleStandard Deviation 0.94
Secondary

Change From Baseline to Post-Treatment in Number of Pauses

Change in the total number of pauses that included breathing (breath pauses). Participant read the Rainbow Passage and data were collected from this task.

Time frame: Baseline 1 (week 1) and Post-Training (week 10)

Population: All participants with baseline and post-training values. Data from the first baseline and the week 10 post-treatment value were used.

ArmMeasureGroupValue (MEAN)Dispersion
Expiratory Muscle Strength TrainingChange From Baseline to Post-Treatment in Number of PausesBaseline (reading) - week 115.89 number of pausesStandard Deviation 8.28
Expiratory Muscle Strength TrainingChange From Baseline to Post-Treatment in Number of PausesPost-training (reading) - week 1016.75 number of pausesStandard Deviation 10.99
Comparison: A mixed model ANOVA with session (pre-post-training) as a main effect and participant as a random factor was run via SAS 9.4. Alpha was set at .05.p-value: 0.052ANOVA
Secondary

Change From Baseline to Post-Treatment in Syntactic Location of Pauses

Change in the location of pauses while breathing produced while reading. We determined where participants took breaths while reading the Rainbow Passage and categorized them according to syntax. Categories included at a major boundary (at the end of an independent clause marked by a period) and at a boundary that is not related to syntax (not a major or minor syntactical location). The number of pauses at each category of boundaries were converted to a percent of the total breaths taken while reading the passage.

Time frame: Baseline 1 (week 1) and Post-Training (week 10)

Population: All participants with baseline and post-training values. Data from baseline (week 1) and post-training (week 10) were used.

ArmMeasureGroupValue (MEAN)Dispersion
Expiratory Muscle Strength TrainingChange From Baseline to Post-Treatment in Syntactic Location of PausesBaseline, boundaries unrelated to syntax8.71 percent of pauses at the boundaryStandard Deviation 13.09
Expiratory Muscle Strength TrainingChange From Baseline to Post-Treatment in Syntactic Location of PausesBaseline, major boundaries47.12 percent of pauses at the boundaryStandard Deviation 37.59
Expiratory Muscle Strength TrainingChange From Baseline to Post-Treatment in Syntactic Location of PausesPost-training, major boundaries46.09 percent of pauses at the boundaryStandard Deviation 18.92
Expiratory Muscle Strength TrainingChange From Baseline to Post-Treatment in Syntactic Location of PausesPost-training, boundaries unrelated to syntax12.33 percent of pauses at the boundaryStandard Deviation 17.36
Comparison: A mixed model ANOVA with session (pre-post-training) as a main effect and participant as a random factor was run via SAS 9.4. Alpha was set at .05.~Results here are for percent of breaths at major boundaries.p-value: 0.931ANOVA
Comparison: A mixed model ANOVA with session (pre-post-training) as a main effect and participant as a random factor was run via SAS 9.4. Alpha was set at .05. Results reflect percent of breaths at boundaries unrelated to syntax.p-value: 0.164ANOVA
Secondary

Change From Baseline to Post-Treatment in Utterance Length

Change in utterance length (# of syllables produced on one breath) throughout the study duration. Participant read the Rainbow Passage and data were collected from this task.

Time frame: Baseline 1 (week 1) and Post-Training (week 10)

Population: All participants who had baseline and post-training values for this measure. Data from the first baseline and the week 10 post-treatment value were used.

ArmMeasureGroupValue (MEAN)Dispersion
Expiratory Muscle Strength TrainingChange From Baseline to Post-Treatment in Utterance LengthBaseline (reading) - week 110.76 syllablesStandard Deviation 3.29
Expiratory Muscle Strength TrainingChange From Baseline to Post-Treatment in Utterance LengthPost-training (reading) - week 1010.39 syllablesStandard Deviation 4.11
Comparison: A mixed model ANOVA with session (pre-post-training) as a main effect and participant as a random factor was run via SAS 9.4. Alpha was set at .05.p-value: 0.113ANOVA
Secondary

Change From Pre-Training to Post-Training in Communication Participation Item Bank

Participants were instructed to use a 4-point Likert scale (3: not at all; 2: a little; 1: quite a bit; 0: very much) to rate if/how their ALS impacts ten hypothetical communicative situations. Participants total scores were then added together, ranging from 0-30, and converted to a T-score ranging from 24.2-71.0. High scores are more favorable, indicating that the participant feels that ALS impacts their communicative participation less than those with lower scores.

Time frame: Pre-Training (week 3) and Post-Training (week 10)

Population: All participants with pre- and post-training scores. Data from the pre-training in week 3 and the week 10 post-treatment value were used.

ArmMeasureGroupValue (MEAN)Dispersion
Expiratory Muscle Strength TrainingChange From Pre-Training to Post-Training in Communication Participation Item Bankpost-training (week 10)48.51 T-score scale pointsStandard Deviation 14.65
Expiratory Muscle Strength TrainingChange From Pre-Training to Post-Training in Communication Participation Item Bankpre-training (week 3)47.78 T-score scale pointsStandard Deviation 15.96
Secondary

Peak Expiratory Flow Rate

Change in cough strength (as measured by peak expiratory flow rate) throughout the study duration, measured using a flow meter that the participant coughs into - single coughs. Data from baseline 2 and pre-training were averaged for the pre--training value.

Time frame: Baseline 2 (week 2), Pre-training (week 3), Post-Training (week 10)

Population: All participants with baseline 2 (week 2) and pre-training values (week 3) and post-training (week 10) data were included.

ArmMeasureGroupValue (MEAN)Dispersion
Expiratory Muscle Strength TrainingPeak Expiratory Flow RatePost-training (week 10)273.47 liters per minuteStandard Deviation 127.69
Expiratory Muscle Strength TrainingPeak Expiratory Flow RatePre-training average265.97 liters per minuteStandard Deviation 141.47
Secondary

Psychosocial Impact of Assistive Devices Scale

A survey assessing how the training device/modality impacts patient's psychosocial functions. The PIADS includes 12 items for competence, 6 for adaptability, and 8 for self-esteem. Participants use a 7-point Likert scale to rate the impact of a device on each item: a maximum negative impact (-3), somewhat negative impact (-2 or -1), zero impact (0), somewhat positive impact (1 or 2), maximum positive impact (3). Total scores range from -78 (maximum negative impact) to 78 (maximum positive impact).

Time frame: Post-treatment (week 10)

Population: All participants with a post-treatment (week 10) score.

ArmMeasureValue (MEAN)Dispersion
Expiratory Muscle Strength TrainingPsychosocial Impact of Assistive Devices Scale28.08 score on a scaleStandard Deviation 26.61
Secondary

Telehealth Satisfaction

Participants rated 15 statements with a 5-point Likert scale ranging from strongly disagree (1) to strongly agree (5). Example statements include: I can easily talk to my health-care provider, I can hear my health-care provider clearly, I can see my health-care provider as if we met in person, I think the care provided via telemedicine is consistent, and I receive adequate attention, telemedicine provides for my health care need, and overall, I am satisfied with the quality of service being provided via telemedicine. Total scores range from 0-75 and individual statement scores ranged from 1-5, with higher scores indicating higher satisfaction with the telepractice modality.

Time frame: Post-Training (week 10)

Population: Only assessed at post-training. Included all participants who completed the scale. Higher values reflect more satisfaction and the score maximum is 75.

ArmMeasureValue (MEAN)Dispersion
Expiratory Muscle Strength TrainingTelehealth Satisfaction60.58 score on a scaleStandard Deviation 7.69
Secondary

Tele-health Session Attendance

% of training sessions scheduled and attended by participants throughout the study duration

Time frame: Measured at the end of training across the entire training period

Population: Participants who completed the training protocol

ArmMeasureValue (MEAN)Dispersion
Expiratory Muscle Strength TrainingTele-health Session Attendance95.37 percentage of sessions attendedStandard Deviation 7.43

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026